Skip to main content

Table 1 Reported cases of gallbladder metastasis from gastric cancer in Japan

From: Synchronous gallbladder metastasis originating from residual gastric cancer: a case report and the review of literature

Case

Year

Age

Sex

Gastric cancer

Gallbladder

Metastatic pathway

Cause of death

Duration/Prognosis

Histological type

Ly

V

N

Dissemination

Preoperative diagnosis

Macroscopic findings

1

1990

44

M

Por

2

0

3

 + 

GB polyps

SMT

L

Carcinomatous meningitis

8 months/Death

2

1996

54

M

ND

ND

ND

ND

ND

ND

SMT

ND

ND

ND

3

1996

63

F

ND

ND

ND

ND

ND

ND

SMT

ND

ND

ND

4

1999

62

M

Sig

2

2

1

ND

GB stones

ND

DIC

4.5 months/Death

5

2002

86

F

Adenosquamous

3

2

1

 + 

WT

WT

L

Acute renal failure

30 days/Death

6

2006

88

M

Endocrine

3

2

2

NA

L or H

 

8 months/Alive

7

2007

54

M

Por

2

1

2

GB stones

WT

L

Obstructive jaundice Carcinomatous peritonitis

5 months/Death

8

2008

71

M

Tub2

1

0

2

 + 

GB stones

L

Carcinomatous peritonitis Pneumonia

53 days/Death

9

2008

76

M

Por

2

2

1

NA

H

Bone metastasis Weakness

43 days/Death

10

2009

54

M

Por

2

1

3

ND

GB stones

SMT

L

 

3 years/Alive

11

2011

66

F

Por

1

0

1

NA

L

 

13 months/Alive

12

2013

50

F

Tub2

3

0

1

Primary GB tumor

WT

L

 

33 months/Alive

13

2014

68

F

Sig

3

1

2

Primary GB tumor

WT

L

 

24 months/Alive

14

2014

62

F

Por

3

2

3

NA

SMT

L

Recurrence of cancer

9 months/Death

15

2014

55

M

Tub2

2

1

3

GB metastasis

SMT

L or H

 

ND

16

2019

66

F

Por + tub2

1

1

3

GB stones Adenomyomatosis

SMT

L

Lymphangitis carcinomatosa

7 months/Death

17

2020

71

M

Sig

0

 + 

3

GB stones

L

Death of cancer

199 days/Death

18

2021

84

M

Por

ND

ND

ND

 + 

Acute cholecystitis

WT

Peritoneal dissemination

 

ND/Alive

Present case

2020

67

M

Sig

1

0

3

GB stones

WT

L

Lymphangitis carcinomatosa

10 months/Death

  1. ND no data, por poorly differentiated adenocarcinoma, sig signet-ring cell carcinoma, tub2 moderately differentiated tubular adenocarcinoma, NA no abnormality, GB gallbladder, WT wall thickness, SMT submucosal tumor, L lymphogenous, H hematogenous